Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Goldkuhle

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 3, 2019
["Transferability": Is GRADE the solution?]Marius Goldkuhle, Tina Jakob, Nina Kreuzberger, et al.
BMJ Open|March 28, 2018
A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancerMarius Goldkuhle, Vikram M Narayan, Aaron Weigl, et al.
The Cochrane Database of Systematic Reviews|March 26, 2025
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphomaNina Kreuzberger, Marius Goldkuhle, Bastian von Tresckow, et al.
The Cochrane Database of Systematic Reviews|December 2, 2024
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphomaMarius Goldkuhle, Nina Kreuzberger, Bastian von Tresckow, et al.
The Cochrane Database of Systematic Reviews|July 13, 2018
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)Marius Goldkuhle, Maria Dimaki, Gerald Gartlehner, et al.
Journal of Clinical Epidemiology|December 14, 2018
Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviewsNicole Skoetz, Marius Goldkuhle, Aaron Weigl, et al.
BMC Medical Research Methodology|November 26, 2024
Exploring the characteristics, methods and reporting of systematic reviews with meta-analyses of time-to-event outcomes: a meta-epidemiological studyMarius Goldkuhle, Caroline Hirsch, Claire Iannizzi, et al.
The Cochrane Database of Systematic Reviews|September 13, 2021
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphomaMoritz Ernst, Annika Oeser, Burcu Besiroglu, et al.
The Cochrane Database of Systematic Reviews|May 5, 2023
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysisAngela Aldin, Burcu Besiroglu, Anne Adams, et al.
Journal of Clinical Epidemiology|November 13, 2019
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence ProfilesNicole Skoetz, Marius Goldkuhle, Elvira C van Dalen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 3, 2019
["Transferability": Is GRADE the solution?]Marius Goldkuhle, Tina Jakob, Nina Kreuzberger, et al.
BMJ Open|March 28, 2018
A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancerMarius Goldkuhle, Vikram M Narayan, Aaron Weigl, et al.
The Cochrane Database of Systematic Reviews|March 26, 2025
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphomaNina Kreuzberger, Marius Goldkuhle, Bastian von Tresckow, et al.
The Cochrane Database of Systematic Reviews|December 2, 2024
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphomaMarius Goldkuhle, Nina Kreuzberger, Bastian von Tresckow, et al.
The Cochrane Database of Systematic Reviews|July 13, 2018
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)Marius Goldkuhle, Maria Dimaki, Gerald Gartlehner, et al.
Journal of Clinical Epidemiology|December 14, 2018
Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviewsNicole Skoetz, Marius Goldkuhle, Aaron Weigl, et al.
BMC Medical Research Methodology|November 26, 2024
Exploring the characteristics, methods and reporting of systematic reviews with meta-analyses of time-to-event outcomes: a meta-epidemiological studyMarius Goldkuhle, Caroline Hirsch, Claire Iannizzi, et al.
The Cochrane Database of Systematic Reviews|September 13, 2021
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphomaMoritz Ernst, Annika Oeser, Burcu Besiroglu, et al.
The Cochrane Database of Systematic Reviews|May 5, 2023
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysisAngela Aldin, Burcu Besiroglu, Anne Adams, et al.
Journal of Clinical Epidemiology|November 13, 2019
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence ProfilesNicole Skoetz, Marius Goldkuhle, Elvira C van Dalen, et al.
Pageof 2